The company
Structure Therapeutics Inc. - American Depositary Shares
GPCR · Nasdaq
GPCR stood above a rising 150-day average in 24 of the last 52 weekly readings, and has been out of that trend for the last 27 weeks. It is 52.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 27
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 1
- Institutions holding
- 185 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 0, Senate 1, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Thomas R. Carper Senate: U.S. Senate eFDSenator | soldspouse | $1k–$15k | 4 Oct 2023filed 2 Nov 2023 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Crespo Blas CollCHIEF MEDICAL OFFICER | sold | 4,008at $36.15 | 21 Sep 2026filed 22 Sep 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 1,300at $45.86 | 1 Sep 2026filed 2 Sep 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 4,539at $47.20 | 1 Sep 2026filed 2 Sep 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 100at $47.83 | 1 Sep 2026filed 2 Sep 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 3,020at $53.13 | 18 Aug 2026filed 19 Aug 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 519at $54.20 | 18 Aug 2026filed 19 Aug 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 400at $55.05 | 18 Aug 2026filed 19 Aug 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 3,100at $49.29 | 4 Aug 2026filed 5 Aug 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 839at $50.03 | 4 Aug 2026filed 5 Aug 2026 |
| Fmr Llc10% owner, Other | sold | 1,367at $50.07 | 22 Jul 2026filed 24 Jul 2026 |
| Fmr Llc10% owner, Other | sold | 16,085at $50.07 | 22 Jul 2026filed 24 Jul 2026 |
| Xichen LinCHIEF SCIENTIFIC OFFICER | sold | 6,278at $50.80 | 14 Jul 2026filed 15 Jul 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCreduced · filed 13 Aug 2026 | 7,810,306$419.2M | -593,143−7.1% |
| WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026 | 7,379,433$396.1M | +119,146+1.6% |
| Avoro Capital Advisors LLCunchanged · filed 14 Aug 2026 | 6,555,555$351.8M | 00.0% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 5,204,212$279.3M | +5,204,212 |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 4,740,072$254.4M | +460,224+10.8% |
| BVF INCreduced · filed 14 Aug 2026 | 3,366,823$180.7M | -92,535−2.7% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 2,806,640$150.6M | +501,183+21.7% |
| ORBIMED ADVISORS LLCadded · filed 14 Aug 2026 | 2,209,400$118.6M | +733,997+49.7% |
| PRINCIPAL FINANCIAL GROUP INCreduced · filed 4 Aug 2026 | 1,752,753$94.1M | -1,011−0.1% |
| AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026 | 1,682,179$90.3M | +244,148+17.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.